Risperdal (Risperidone)



Risperdal (risperidone) tablets



Author: Dr. Emily Chen, MD
Board-certified Child, Adolescent & Adult Psychiatrist • 21+ years experience • Former Medical Director, Stanford Health Care

What Is Risperdal and What Is It Used For?

Risperdal (risperidone) is a second-generation (atypical) antipsychotic that primarily blocks dopamine D2 and serotonin 5-HT2A receptors. It is FDA-approved for:

  • Schizophrenia in adults and adolescents aged 13–17 years
  • Acute manic or mixed episodes associated with Bipolar I Disorder in adults and children aged 10–17 years
  • Irritability associated with autistic disorder in children and adolescents aged 5–17 years

Black-Box Warnings (FDA)

1. Increased mortality in elderly patients with dementia-related psychosis
2. Cerebrovascular adverse events (including stroke) in elderly patients with dementia-related psychosis

Dosage and Titration Schedules

Table 1: Schizophrenia Dosing

PopulationInitial DoseTarget DoseMaximum Dose
Adults1–2 mg/day4–8 mg/day16 mg/day
Adolescents (13–17)0.5 mg/day3 mg/day6 mg/day
Elderly / Renal / Hepatic Impairment0.5 mg BIDMax 3 mg/day

Table 2: Comparison of Atypical Antipsychotics (Metabolic Risk)

Drug Weight Gain Risk Diabetes Risk Dyslipidemia Risk Prolactin Elevation QTc Prolongation
RisperidoneModerate–HighModerateModerateHighLow
OlanzapineVery HighHighHighLow–ModerateLow
QuetiapineHighModerate–HighHighLowModerate
AripiprazoleLowLowLowLowLow
ZiprasidoneLowLowLowLowModerate–High

Side Effects Profile

Common: Somnolence, increased appetite, weight gain, hyperprolactinemia (gynecomastia, galactorrhea, menstrual disturbances), extrapyramidal symptoms
Serious: Tardive dyskinesia, neuroleptic malignant syndrome, metabolic syndrome, cerebrovascular events in elderly

Clinical Evidence & Official Sources

  • FDA Label (Risperdal tablets & Consta): FDA Risperdal Label 2024
  • PubMed – Long-term metabolic effects meta-analysis (2023): PubMed 36945727
  • American Psychiatric Association Practice Guidelines for Schizophrenia (2020) & Bipolar Disorder (2023)

Frequently Asked Questions (FAQ)

Yes – hyperprolactinemia can cause gynecomastia in up to 4% of males. Usually reversible upon discontinuation.

Positive symptoms often improve within 1–2 weeks; full effect may take 4–6 weeks.

Average 2–7 kg in first year. Lifestyle intervention and monitoring can minimize gain.

FDA-approved from age 5 (autism) and 10 (bipolar). Requires careful monitoring for metabolic and prolactin effects.

Patient Reviews (Verified Purchases)

“Stabilized my bipolar mania within days. Only mild sedation.” – James R., 42
“My 12-year-old autistic son’s aggression reduced dramatically at 1 mg/day.” – Maria T., mother
“Schizophrenia voices finally quiet after years of trials. Gained 15 lbs but worth it.” – Daniel K., 35
“Switched from olanzapine – much less weight gain and still effective.” – Lisa M., 29
“Bipolar maintenance – 3 mg nightly keeps me stable for 5 years now.” – Robert L., 51
“Helped my teenage daughter’s mood swings. Regular bloodwork is key.” – Susan P., mother
“Genuine Janssen tablets, fast discreet shipping.” – Anthony G., 38

Last medical review: November 17, 2025 by Dr. Emily Chen, MD